CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

CUSIP: 14888U101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
123,180,519
Total 13F shares
65,840,014
Share change
+2,957,971
Total reported value
$253,546,747
Put/Call ratio
34%
Price per share
$3.85
Number of holders
128
Value change
+$11,634,204
Number of buys
63
Number of sells
67

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2020

As of 31 Mar 2020, CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,840,014 shares. The largest 10 holders included BlackRock Inc., STATE STREET CORP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MANGROVE PARTNERS, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, and SCHRODER INVESTMENT MANAGEMENT GROUP. This page lists 128 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.